COX-2 inhibitors in cancer treatment and prevention, a recent development

Anti-cancer Drugs
Xiao-Chun Xu

Abstract

Epidemiological and experimental studies have demonstrated the effect of non-steroidal anti-inflammatory drugs (NSAIDs) in the prevention of human cancers. NSAIDs block endogenous prostaglandin synthesis through inhibition of cyclooxygenase (COX) enzymatic activity. COX-2, a key isoenzyme in conversion of arachidonic acid to prostaglandins, is inducible by various agents such as growth factors and tumor promoters, and is frequently overexpressed in various tumors. The contribution of COX-2 to carcinogenesis and the malignant phenotype of tumor cells has been thought to be related to its abilities to (i) increase production of prostaglandins, (ii) convert procarcinogens to carcinogens, (iii) inhibit apoptosis, (iv) promote angiogenesis, (v) modulate inflammation and immune function, and (vi) increase tumor cell invasiveness, although some studies indicated that NSAIDs have COX-2-independent effects. A number of clinical trials using COX-2 inhibitors are in progress, and the results from these studies will increase our understanding of COX-2 inhibition in both cancer treatment and prevention. The combination of COX-2 inhibitors with radiation or other anti-cancer or cancer prevention drugs may reduce their side effects in future ...Continue Reading

References

Jun 1, 1977·British Journal of Cancer·A BennettT Zebro
Dec 15, 1991·The New England Journal of Medicine·M J ThunC W Heath
Jun 23, 1971·Nature: New Biology·J B Smith, A L Willis
Jul 1, 1994·Journal of Veterinary Internal Medicine·D W KnappT Kuczek
Mar 1, 1994·Epidemiology·D M Schreinemachers, R B Everson
Jul 1, 1993·Carcinogenesis·R C MoonC C Sigman
May 6, 1993·The New England Journal of Medicine·F M GiardielloG J Offerhaus
Jun 2, 1993·Journal of the National Cancer Institute·E R GreenbergR Haile
Dec 22, 1995·Science·B Frantz, E A O'Neill
Oct 1, 1995·Cancer·E M Funkhouser, G B Sharp
Jul 17, 1996·Journal of the National Cancer Institute·K M EganG A Colditz
Mar 1, 1996·Epidemiology·R E HarrisW B Farrar
Dec 1, 1996·Gastroenterology Clinics of North America·R N DuBoisW E Smalley
Mar 1, 1997·Neurology·W F StewartE J Metter
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TsujiiR N DuBois
May 1, 1997·The Journal of Clinical Investigation·H ShengR N DuBois
Jan 1, 1997·Advances in Pharmacology·W E Smalley, R N DuBois
Jan 27, 1998·The Journal of Biological Chemistry·F ZhangA J Dannenberg
Sep 16, 1998·Current Opinion in Chemical Biology·L J Marnett, A S Kalgutkar
Oct 28, 1998·Journal of the National Cancer Institute·M M Taketo
Nov 12, 1998·Journal of the National Cancer Institute·M M Taketo
Nov 27, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J R Vane, R M Botting
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·K Müller-DeckerG Fürstenberger
Feb 7, 2001·British Journal of Cancer·J E CastelaoR K Ross
Jun 7, 2000·The Journal of Clinical Investigation·C S WilliamsR N DuBois
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Aug 10, 2000·Cancer·R YoshimuraS Wada
Sep 6, 2000·Nature Medicine·C J TorranceC M Discafani
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y CaoS M Prescott

❮ Previous
Next ❯

Citations

Nov 7, 2008·Histochemistry and Cell Biology·Girieca Lorusso, Curzio Rüegg
Jun 11, 2005·Virchows Archiv : an International Journal of Pathology·Miguel García-GonzálezJosé Cameselle-Teijeiro
Jul 3, 2007·International Ophthalmology·Pinar C OzdalMiguel N Burnier
Jun 11, 2011·International Urology and Nephrology·Alejandro D Soriano-HernándezIvan Delgado-Enciso
Jun 11, 2009·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Zhixiong ChenQiong Huang
Sep 21, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Christopher BlackmoreAru Narendran
Dec 12, 2003·European Urology·Christian WülfingHansjürgen Piechota
Mar 6, 2003·Cancer Letters·Tajamul HussainHasan Mukhtar
Aug 21, 2003·Drug Discovery Today·Jonathan P Laye, Jason H Gill
Aug 7, 2003·Current Opinion in Pharmacology·Steven J ShiffDiana L Santini
Jun 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A C DrakeM G Dunlop
Jan 22, 2004·Viral Immunology·Sarah A Steer, John A Corbett
Mar 17, 2009·Metabolic Syndrome and Related Disorders·Pooja PothiwalaSubhashini Yaturu
Aug 29, 2003·Journal of Clinical Pathology·C J van der WoudeH Moshage
Mar 31, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Grzegorz SokołowskiFilip Gołkowski
Jan 19, 2012·World Journal of Gastroenterology : WJG·Fei YeXiao-Chun Xu
Sep 28, 2000·Molecular Medicine Today·Y Kloog, A D Cox
Apr 23, 2004·Expert Opinion on Investigational Drugs·Michalis V Karamouzis, Athanasios G Papavassiliou
Nov 30, 2002·Expert Opinion on Investigational Drugs·David G Menter
Mar 7, 2009·Cancer Investigation·António M F ArúajoMarta Soares
Oct 1, 2005·Cancer Investigation·Isa E L M KuppensJ H M Schellens
Dec 13, 2006·Cancer Investigation·Kenneth S Wilson
Oct 12, 2004·The Journal of Pathology·Outi E PäiväniemiUlla-Stina Salminen
Mar 15, 2005·Chest·Sadik A KhuderDouglas J Federman
Oct 10, 2013·International Forum of Allergy & Rhinology·Jeffrey D SuhMarilene B Wang
Jul 10, 2009·The Journal of Investigative Dermatology·Arjen JoosseTamar Nijsten
Aug 16, 2005·Clinical Lung Cancer·Jenny T MaoSteven M Dubinett
Feb 27, 2007·Cancer Letters·Xiaoying ZhangChandradhar Dwivedi
Jan 24, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mona MoussaTarek Swellam
Dec 7, 2007·International Journal of Cancer. Journal International Du Cancer·Jun-Feng LiuPaul A Drew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.